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The purpose of the present study was to clinically and histologically investigate the influence of 
macrophage depletion on the development of experimental autoimmune pigment epithelial membrane 
protein-induced uveitis (EAPU), and experimental melanin-protein induced uveitis (EMIU) in the Lewis 
rat. EAPU is mainly characterized by pigment epitheliitis. Posterior mononuclear cell accumulations 
enclose and destroy the retinal pigment epithelium (RPE). In EMIU the inflammation is specifically 
localized in the uvea.
EAPU was induced by immunization with RPE membrane protein, and EMIU was evoked by 
immunization with purified choroidal melanin. Systemic treatment with dichloromethylene diphos- 
phonate (Cl2MDP)-containing liposomes just before the expected beginning of the clinical signs of EAPU 
(at day 7 and 9 after immunization) resulted in a considerable delay of the uveitis process. In the treated 
animals the typical plaque shaped cell accumulations (containing many macrophages) along the RPE 
were lacking. Two weeks after the treatment, severe rebound EAPU developed. Local treatment by 
subconjunctival liposome injections did not exert any effect on EAPU. In EMIU, macrophage depletion by 
systemic treatment did not noticeably influence the clinical and histological development of the 
inflammation.
Systemic treatment at the peak stage of EAPU (at day 12 and 14 after immunization) resulted in the 
rapid disappearance of the clinical signs of uveitis. Vitreous and anterior chamber cells were virtually 
absent two days later. This situation remained unchanged until the experiment was terminated two 
weeks later. Already deposited cell accumulations along the RPE did not regress but stopped their 
progression.
Hematogenous macrophages thus appear to play a crucial role in the development of EAPU but the 
effect of early macrophage depletion on EAPU appeared to be temporary due to blood repopulation, A 
possible explanation for the differential influence of macrophage depletion on EAPU and EMIU is 
discussed, and is based on differences in immunopathogenesis, © 1997 Academic Press Limited
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1* Introduction
Three markedly different types of experimental auto­
immune uveitis have been described which can. be 
evoked in Lewis rats by immunization with uveoretinal 
antigens. In experimental autoimmune uveoretinitis 
(EAU) induced by photoreceptor proteins, inflamma­
tory foci develop within the photoreceptor cell layer 
which is the target tissue (Faure, 1980; Gery, 
Mochizuki and Nussenblatt, 1986). In experimental 
autoimmune pigment epithelial membrane protein- 
induced uveitis (EAPU), the RPE is the target tissue, 
and inflammatory foci do not develop within the 
neuroretina. Mononuclear cells (mainly infiltrated 
macrophages) accumulate along both sides of the 
RPE-Bruch’s membrane layer which is destroyed. 
Uveitogenic pigment epithelial proteins (PEP) with 
Mr 65, 43 and 2 8 /3 0  (PEP-65, PEP-43 and PEP-
* Corresponding author: Dr R. M. Broekhuyse.
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2 8 /3 0 )  have been isolated from the microsomal 
fraction of RPE cells, and evoke EAPU after immuni­
zation (Broekhuyse et a l, 1992b; Broekhuyse and 
Kuhlmann, 1997). In experimental melanin protein- 
induced uveitis (EMIU; also called experimental auto­
immune anterior uveitis, EAAU), the primary inflam­
mation is confined to the uvea whereas the retina is 
spared. The inciting antigen can be prepared from the 
melanin granules from the bovine retinal pigment 
epithelium (RPE) or from the uveal tissues (Broekhuyse 
et al., 1991, 1992a; Broekhuyse and Kuhlmann, 
1993; Chan et al., 1994; Bora et al., 1995). Little is 
known about the immunopathogenesis of the latter 
two forms of experimental uveitis. In autoimmune 
diseases like experimental autoimmune encephalo­
myelitis (EAE) and EAPU, EDI positive macrophages 
are known to play a crucial role (Huitinga et al., 
1995; Broekhuyse et al., 1996). In these models, and 
in experimental autoimmune arthritis, and nephritis, 
the cells that infiltrate the target tissues first have been
© 1997 Academic Press Limited
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shown to be newly recruited ED1-J- exudate macro­
phages. Data obtained from macrophage elimination 
studies indicate that the newly recruited macrophages 
are crucial for the generation of clinical signs (Bauer 
et al., 1996, review).
In the present study we have applied the technique 
of liposome-mediated macrophage depletion in order 
to investigate the role of macrophages in EAPU and 
EMIU. Liposomes containing dichloromethylene di- 
phosphonate (CI2MDP) are known to be phagocytized 
by macrophages in the spleen, the liver, and by blood 
monocytes (Van Rooijen et al., 1990; Huitinga et al., 
1990, 1992). Once internalized, C12MDP is released 
and kills the cells (Van Rooijen, 1989). EAPU and 
EMIU have been evoked in Lewis rats, and the animals 
have been injected with the liposomes immediately 
before the start and at the peak stage of uveitis in order 
to investigate a possible prevention or amelioration of 
uveitis.
2. Materials and Methods
Antigens
Two uveitogenic antigens were prepared to evoke 
EAPU, the Triton X -100 soluble-(TS) fraction of RPE 
microsomal cell membranes (RPE-TS), and its main 
constituent the 65 kD pigment epithelial protein PEP- 
65 (Broekhuyse et al., 1992b, 1996). Briefly, RPE cells 
were isolated from the cups of fresh bovine eyes by 
brushing and rinsing. The cells were freed from rod 
outer segments and other tissue fragments by five to 
seven sedimentations from buffered sucrose (0*25 m; 
15 h i m  phosphate buffer; pH 7*3) at 140 g (10 min, 
20°C). The RPE cells were extracted by phosphate 
buffered physiological saline pH 7*4 (PBS), and the 
insoluble membranous 10 5 g sediment was extracted 
by Triton X-100. The combined supernatants con­
taining the RPE-TS protein were stored at — 25°C. Its 
main constituent PEP-65 was prepared from RPE-TS 
by preparative sodium dodecyl sulfate (SDS)-polyacryl- 
amide gel electrophoresis (PAGE), and electro-elution. 
The obtained protein was precipitated from the 
detergent solution by cold acetone precipitation (0°C), 
dried under nitrogen, dissolved in 1 % Triton X-100 in 
PBS, and stored at -2 5 °C . PEP-65 was used as 
uveitogen in the initial studies of EAPU, and its activity 
was compared to RPE-TS.
Choroidal melanin was purified in order to evoke 
EMIU. Bovine eye cups were obtained as described 
above, and the choroid was removed with forceps. The 
tissues were rubbed in a mortar with a rough surface 
with minimal amounts of water. The suspended 
material was filtered through gauze, and the ex­
traction of the tissue was repeated five times. The 
combined filtered suspensions were centrifuged (104 g , 
10 min, 4°C), and the crude sedimented melanosomes 
were washed with PBS. Afterwards they were sus­
pended in 2 %  SDS in distilled water (1 ml for the
melanin of each choroid), and heated at 75°C for 
10 min. After centrifugation, the purified melanin was 
washed twice with distilled water at room tem­
perature, and stored in water at — 25°C (Broekhuyse 
and Kuhlmann, 1993).
The determinations of soluble, membrane-, and 
melanin-protein, SDS-PAGE, the check for purity by 
SDS-PAGE and immunoblotting have been described 
previously (Broekhuyse et al., 1991, 1992a, b, 1993).
Animal Experiments
Groups of female Lewis rats [LEW/01a/Hsd(albino); 
1 5 0 -1 8 0  g] composed as represented in Table I, were 
immunized with 150 /¿g RPE-TS, or 100 jig PEP-65 to 
evoke EAPU, and with 10 or 25 ¡ig melanin-pr otein to 
induce EMIU, The animals originated from Harlan 
Olac Ltd, Bicester, England. Half the antigen dose was 
emulsified in Freund’s complete adjuvant (CFA; Difco 
Laboratories, Detroit, MI, U.S.A.), and injected in the 
hind foot pads {0-1 ml per pad). The other half was 
mixed with 1 ml PBS containing 2 ¡ig pertussis toxin 
(Sigma Chemical Company, St. Louis, MO, U.S.A.) and 
injected intraperitoneally. The 10 /¿g melanin-protein 
dose was injected with 1 ¡ig toxin. General controls 
were similarly injected with the toxin and with 
CFA/PBS emulsions but without antigen.
Shortly before, or after the start of EAPU and EMIU, 
the animals were intravenously injected with 1-8 ml 
Cl2MDP-liposomes, PBS-containing liposomes, or PBS, 
as indicated in the Results section (Table I). In a 
separate experiment, 50 ¡A ClaMDP-liposomes were 
injected subconjunctivally at the right eyes of five rats 
at day 7 and 9 after immunization. Liposomes were 
prepared as described (Huitinga et al., 1995). C12MDP 
was a gift of Boehringer, Mannheim, Germany, 
Starting from day 9 after immunization, the eyes were 
examined daily for 2 weeks and subsequently twice a 
week. Clinical signs of uveitis were monitored by direct 
slit-lamp biomicroscopy after dilation of the pupils by 
tropicamide (0*17%). The observations were graded 
on a scale of 0 -4  as described for EAPU (Broekhuyse et 
al., 1992b), and for EMIU (Broekhuyse et al, 1991). 
The experiments were terminated 2 to 4 weeks after 
immunization as indicated in Table I, and the 
histopathology of eyes, liver and spleen was examined.
Histopathology
Eyes were fixed in Bouin solution, and processed 
according to standard histological techniques. All eyes 
were sectioned parallel to the optic axis. Macrophage 
depletion phenomena were checked in frozen sections 
of spleen, liver and in bloodsmears of rats 2 weeks after 
immunization. Bloodsmears were stained with May 
Grunwald-Giemsa, and frozen sections were stained 
with monoclonal antibody EDI as described (Broek­
huyse et a l, 1996).
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T a b l e  I
The effect of treatment with Cl2MDP liposomes on the development o f EAPU and EM IU
Treatment* Incidence of uveitisf Clinical uveitis scores§
Inciting Liposome Early phase Late phase
antigenH type Days Incidence Mild Severe [day 12-15] [day 26-30]
PEP-6 5 C12MDP 7 and 9 4/4 3 1 1-6 +  0-3 [13]** 3-3 +0-4 [26]**
PEP-65 PBS 7 and 9 5/5 3 2 2-4+ 0-4 [13]**** 1-3+0-3 [26]
PEP-6 5 [PBS solution] 7 and 9 4/4 0 4 3-4±03 [13] 1-3 +0-5 [26]
RPE-TS C12MDP 7 and 9 4/7 4 0 0-0 [12-15]** 2 -1 + 0 6  [30]***
RPE-TS PBS 7 and 9 7/7 0 7 2-5±0-3 [12] 1-5 ±0-6 [30]
RPE-TS ClaMDP 12 and 14 5/5 3* 2-5±0-3 [12] 
03  +  0-1 [15]** 0-8 ±0-4 [26]**
RPE-TS PBS 12 and 14 5/5 2t 3* 2 '9 ± 0 4  [12]
2-4 +  0 4  [15] 1-8 ±0-4 [26]
Melanin/2 5 C12MDP 7 and 9 4/4 0 4 4-0 +  00  [12]
Melanin/25 PBS 7 and 9 2/2 0 2 4-0 +  0-0 [12]
Melanin/25 [PBS-solution] 7 and 9 3/3 0 3 4-0+ 0-0 [12]
Melanin/10 C12MDP 7 and 9 and 12 4/4 0 4 4-0 ±0-0 [14]
Melanin/10 PBS 7 and 9 and 12 2/2 0 2 4-0 ±0-0 [14]
* C12MDP, PBS: mannosylated liposomes containing C12MDP or PBS were injected intravenously shortly before or after the start of EAPU or 
EMIU, i.e. at days 7 and 9 (and 12) (prevention) or 12 and 14 (therapy), respectively. [PBS solution], PBS injected without liposomes.
t Maximum score attained within the entire experimental period. Mild, score 1 and 2; severe, score 3 and 4.
% No maximum inflammation reached in ail rats; incidences at day 12 are represented, the time of the first injection of liposomes close to 
the inflammatory peak activity of EAPU.
§ Mean score ( ± s .e .m .). Early phase, day 12-15 after immunization, shortly after the start of EAPU or EMIU (peak of inflammation) when 
the most characteristic effects of treatment are noticed; late phase, day 26-30. P values represent analysis of scores of Cl2MDP-liposomes treated 
rats vs, control rats. **P < 0-01, ***P <  0*05. **** Analysis of PBS-liposomes-treated rats vs. PBS-injected rats: P  <  0-01.
U Melanin injected in two different melanin-protein doses to evoke EMIU: 25 (ig (2 /¿g pertussis toxin), and 10 /¿g (1 /¿g pertussis toxin).
Statistical Analysis
For testing the significance of difference in uveitis 
scores, Fisher’s exact test was applied.
3 . Results
Clinical Effects of Macrophage Depletion
EAPU treatment, Cl2MDP-lipo somes at day 7 and 9; 
controls Table I represents the results of two types of 
experiments in Lewis rats which were immunized to 
develop EAPU. In the first type of experiment, C12MDP- 
liposomes were injected intravenously just before and 
at the day on which clinical signs of ocular 
inflammation were expected to start. The results of 
slit-lamp examinations show that PEP-65 in PBS 
controls evoked severe EAPU (score 3*4 at day 13). If 
the rats were treated with C12MDP-liposomes at day 7 
and 9 after immunization, only a very mild vitritis was 
noticed (score 1*6 at day 13). The inhibition of uveitis 
was not permanent because EAPU still developed two 
weeks later (score 3*3 at day 26). PBS~liposomes 
(control treatment) also had a weak inhibiting effect on 
the disease ; the highest score attained in controls was 
2*4 (day 13). The scores of both control groups finally 
decreased to 1*3 (day 26). Two similar experiments 
(not recorded in Table I) confirmed this effect of PBS- 
liposomes. It occurred from day 12 to 20, and 
disappeared afterwards. Hence, all three groups de­
veloped uveitis but according to different patterns. 
Because the experiments described below showed that 
RPE-TS and PEP-65 were equally well suitable to 
evoke EAPU while RPE-TS was easier to prepare, this 
antigen was further used as the inciting uveitogen.
Table I shows that control rats injected with RPE-TS 
developed severe EAPU (peak inflammation at day 12 ; 
score 2*5) at day 12 whereas Cl2MDP-liposomes 
treatment totally inhibited the development of clinical 
EAPU at that time. Like in PEP-65-induced EAPU 
treated with Cl2MDP-liposomes, the disease still de­
veloped a few weeks later, in controls on the other 
hand, the signs of clinical EAPU gradually decreased. 
ClgMDP-liposomes deposition subconjunctivally at one 
eye, did not result in macrophage depletion and 
suppression of EAPU. The uveitis scores were equally 
high for treated (OD) and untreated eyes (OS) at the 
time uveitis was at its peak of inflammation (scores 3*0 
to 3-3 at day 13).
EAPU treatment, Cl2MDP-liposomes at day 12 and 
14; controls In the second type of experiments, 
therapeutic treatment of EAPU at the time of its peak 
stage was investigated. Cl2MDP-liposomes were intra­
venously injected at day 12 and 14 when moderate to 
severe EAPU was clinically manifest (Table I), The 
treatment resulted in a rapid decrease of the slit-lamp 
score from 2*5 at day 12 to 0-3 at day 15 whereas 
control rats injected with PBS-liposomes exhibited 
little change of their ocular condition. During the
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Fig. 1, Histopathology of EAPU in Lewis rats treated with CI2MDP»liposomes (suppression) or PBS-liposomes (controls), (A) 
Severe EAPU in controls at day 13 after immunization (PBS-liposomes at day 7 and 9). Subretinal exudate, subretinal and 
choroidal cell accumulations extending into the dystrophic ciliary body. The RPE has been eliminated, x 170. (B) Absence of 
EAPU at day 13 after immunization as a result of suppression of uveitis by macrophage elimination by ClaMDP-liposome 
injections at day 7 and 9. Scarce mononuclear cells infiltrated into the choroid and vitreous, x 340. (C) Severe EAPU at day 
26 after immunization following initial suppression by Cl2MDP-liposome injections at day 7 and 9. Dense chorio-subretinal 
mononuclear cell accumulations along the destroyed RPE. No inflammatory foci within the neural retina, x 340. (D) Late stage 
(day 26 after immunization) of very severe EAPU after treatment of the disease by Cl2MDP-liposome injections at day 12 and 
14 after immunization. Subretinal fibrosis and decay of phagocytes, irregular nuclear layers, dystrophic and absent rod outer 
segments. x l7 0 .
experimental period of 26  days no recurrence of 
clinical EAPU was observed in treated rats while the 
score in controls changed from 2-9 to 1-8 mainly 
because vitritis gradually decreased.
EM1U treatment, Cl2MDP-liposomes at day 7 and 9 
(and 12);  controls EMIU was induced by two different 
doses melanin-protein, 10 and 25 /¿g, accompanied by 
1 and 2 /¿g pertussis toxin, and the rats were injected 
with liposomes at day 7 and 9 or at day 7 and 9 and 12,
respectively. Table I shows that none of the treatments 
had any influence on the clinical development of 
EMIU. The scores reached the maximum of 4 in the 
eyes of treated as well as control rats.
Histopathology
EAPU controls: PBS and PBS-liposomes at day 7 and 
9 According to the described clinical observations, the 
development of EAPU appeared to be effectively
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B
Fig. 2. Histopathology of EMIU in the Lewis rat. (A) Day 12 after immunization, clinical onset of inflammation in  PBS-solution 
Injected controls. Massive mononuclear cell infiltration of the ciliary body predominantly consisting of small lymphocytes (small 
arrows). The ciliary epithelium is at the left (big arrows), x 340. (B) Day 14 after immunization. The animals were treated with 
Cl^MDP-liposomes at day 7 and 9. The choroid is invaded by many mononuclear cells whereas the retina and its RPE remain 
unaffected, x 340.
inhibited by macrophage depletion. During the de­
velopment of PBS-liposome treated EAPU (controls), 
the severity of the clinically observed inflammation 
closely correlated with those seen histopathologically. 
In sections of eyes with slit-lamp score 1 (some 
anterior chamber cells and slight iris vessel dilatation) 
the entire uvea was slightly infiltrated by mononuclear 
cells. At slit-lamp scores 2 to 4, severe choroiditis had 
developed during days 1 -5  after the onset of EAPU (at 
day 9). At the same time, cell accumulations occurred 
focally adjacent to the RPE-Bruch's membrane layer, 
some with the appearance of small Dalen-Fuchs-like 
nodules. These accumulations enlarged further during 
the development of severe uveitis, and extended along 
both sides of the RPE-Bruch’s membrane layer while 
the enclosed structure of this layer was destroyed [Fig. 
1(A)]. No polymorphonuclear cells or plasma cells 
were found. The majority of the mononuclear cells 
were macrophages, but these cells were not found 
within the photoreceptor cell layer. No inflammatory 
foci were found to develop within the neuroretina.
Four weeks after immunization of the controls, the 
cell accumulations had extended still further along 
both sides of the RPE suggesting that the process of cell 
accumulation progressed continuously. Many ac­
cumulations were situated at the chorioretinal per­
iphery, and in very severe inflammatory reactions the 
ciliary body became involved. The layer of retinal rods 
showed thinned areas without the presence of inflam­
matory cells, and was focally absent. The iris and 
ciliary body contained only slight mononuclear cell 
infiltrations even at this advanced stage, Sclera and 
cornea were not involved. We found no differences 
between the patterns of EAPU development evoked by 
PEP-6 5 and by RPE-TS. The higher slit-lamp scores in
rats with PEP-65 induced EAPU and injected with PBS 
histopathologically corresponded to more severe cho­
roiditis while the cell accumulations were more 
extensive.
EAPU treatment, Cl2MDP-liposomes at day 7 and 9 
Liver and spleen sections exhibited efficient elimination 
of EDI H- macrophages by the Cl2MDP-liposomes in 
agreement with a previous report (Van Rooijen et al., 
1990), while bloodsmears showed the presence of 
enlarged and vacuolated monocytes indicating that 
the cells were affected by the Cl2MDP-liposomes 
(Huitinga et al., 1992). In contrast to the observations 
in control rats, clinical uveitis scores and histopatholo- 
gical observations often did not correspond in the 
treated groups. In the early stage [day 13], chorio­
retinal cell infiltrations were absent in the RPE-TS- 
immunized rats treated with Cl2MDP-liposomes which  
were clinically without signs of uveitis. Yet, slight 
vitreous cell infiltrations were found in eye sections 
[Fig. 1(B)]. Some small chorioretinal inflammatory foci 
were found in the similarly treated PEP-6 5-immunized 
rats indicating a slightly higher pathogenicity of this 
antigen at the applied dose. Two weeks later, severe 
rebound EAPU developed in both groups. Extensive 
cell accumulations were then noted along both sides of 
the RPE [Fig. 1(C)]. At this late stage, the choroid and 
retinal photoreceptor layer became more or less 
dystrophic, and the rod outer segments were often 
disappearing, depending on the severity of EAPU that 
developed. The phenomena further closely resembled 
EAPU in controls at its peak stage,
Subconjunctivally injected Cl2MDP~liposomes did 
not inhibit EAPU, and the eyes of these rats and the 
corresponding controls exhibited the typical histo­
846 R. M. BROEKHUYSE
logical features of the peak stage of severe EAPU at the 
moment of termination of the experiment, day 13. 
Liver and spleen sections of both groups did not exhibit 
EDI +  macrophage depletion.
EAPU controls: PBS-liposomes at day 12 and 14  The 
histopathology of the early [day 12 and 15] and late 
[day 26] stages exhibited a similar appearance as 
noted in undisturbed EAPU development at the same 
timepoints,
EAPU treatment, Cl2MDP-liposames at day 12 and 1 4  
In these experiments, the C12MDP- and PBS-liposomes 
were injected at the peak stage of EAPU development 
of the group. The histopathological features of this 
stage in controls have been described above. Clinically, 
the treated group exhibited a sudden drop in uveitis 
activity by the disappearance of vitreous and anterior 
chamber cells during the two days following the 
injections (as reflected in a drop in the uveitis score, 
Table I). However, both the sections of eyes enucleated 
at day 15 and at day 26 exhibited the characteristic 
histopathological features of the peak stage of EAPU. 
Hence, already deposited cell accumulations along the 
RPE [Fig. 1(D)] seemed neither to regress nor to 
expand during the period of disappearance and 
absence of the clinical uveitic changes (days 12-26). 
The number of inflammatory foci also remained 
constant during this period.
EM1U treatment: Cl2MDP-liposomes at day 7 and 9, 
and 7 and 9 and 12; controls Histopathological 
examination confirmed the clinical observation that 
Cl2MDP-liposome treatment did not inhibit or ameli­
orate EMIU. At the onset of EMIU, the entire uvea was 
densely infiltrated by mononuclear cells [predomin­
antly lymphoid cells; Fig. 2(A)]. The anterior uvea was 
swollen and atrophic, These aspects were not different 
from the ocular histopathology of the PBS-liposome 
and PBS-solution control groups, The neuroretina was 
neither affected in the controls nor in the treated rats 
[Fig. 2(B)]. Sections of liver and spleen showed an 
effective depletion of macrophages.
General controls: no antigen, no treatment In the eyes 
of the general controls w e did not find any sign of 
inflammation.
4. Discussion
Effect o f Cl2MDP-liposomes
Among the many possibilities to stop uveoretinitis 
especially corticosteroids, and more recently cyclo­
sporin have been used in patients. The latter substance 
also suppresses EAU, EMIU and EAPU as these are T~ 
cell dependent diseases (Gery et al.t 1986; Broekhuyse 
e t’al., 1992a; 1992b; 1993). As described above 
(Introduction), these forms of autoimmune uveitis
exhibit different characteristics, and are evoked by 
antigens originating from different retinal or uveal cell 
types. The present study shows that hematogenous 
macrophages are of crucial importance for the gen­
eration of EAPU because macrophage depletion by 
ClgMDP-containing liposomes results in a two weeks 
lasting suppression of EAPU. This treatment is es­
pecially effective if applied just before the appearance 
of the first clinical signs of inflammation, i.e. at day 7 
and 9. Treatment at day 8 and 10 appeared to be 
equally effective but injections at earlier or later points 
of time injection were less inhibitory (results not 
shown), in agreement with the findings for EAE 
suppression by the same protocols (Huitinga et aLt 
1990). Previous studies have demonstrated that 
Cl2MDP-containing liposomes have no effect on the 
functioning of other cells of the immune system 
(Claassen, Van Rooijen and Claassen, 1990). Lipo- 
somes-encapsulated C12MDP is internalized by the 
macrophages in liver and spleen, and by the blood 
monocytes (Van Rooijen, 1989; Huitinga et al., 1990; 
1992). As a result, the relative concentration of 
monocytes decreases whereas increased proportions of 
enlarged and desintegrating blood monocytes, and 
polymorphonuclear cells are observed after liposome 
injections. Repopulation of the depleted tissues and 
blood has been observed within two weeks. This 
corresponds to the period of about two weeks after 
which EAPU started to develop after the initial 
suppression by Cl2MDP-liposome injections at day 7 
and 9. Macrophage depletion thus seems to be the sole 
or main cause of the suppression of EAPU. PBS- 
liposomes slightly ameliorate EAPU, presumably be­
cause they are similarly phagocytized by blood 
monocytes as Cl2MDP~liposomes, and occupy phago­
cytic capacity.
Ocular penetration of liposomes before the onset of 
uveitis in a way that noticeably influences the RPE or 
other crucial tissue cells in EAPU seems unlikely. 
Investigations of the central nervous system using the 
same conditions and type of liposomes showed that the 
liposomes could not cross the blood-brain barrier until 
it was damaged by the inflammatory response (Huit­
inga, 1992). We did not observe histological alteration 
of retina or uvea in the period between the first 
intravenous liposome injection and the onset of EMIU 
when the liposome concentrations were highest while 
the blood-ocular barrier was still intact (Broekhuyse et 
al., unpublished result). Subconjunctivally deposited 
Cl2MDP-liposomes did not exert any influence on the 
development of EAPU showing that these liposomes do 
not easily migrate through the tissues. Furthermore, 
no focal modification of the disease process was noted 
during the development of the uveitis process when 
(remaining) liposomes could have entered the eye via 
the damaged blood-ocular barrier. At that site, the 
functionally important RPE cells were immediately 
destroyed by infiltrating effector cells. In agreement 
with thkse considerations, the features of EMIU as well
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a s  of EAPU development in Cl2MDP-Iiposome injected 
rats were the same as in PBS-solution injected controls.
Immunopathogenic Mechanisms in EAPU and EMIU
A marked difference between EAPU, and models like 
EAE, EMIU and EAU concerns the characteristic 
massive posterior influx of macrophages in EAPU. 
These cells accumulate along both sides of the RPE 
and  the presence of such high numbers of blood-born 
macrophages suggests that these cells are important 
effector cells. In general, the important role of (EDI + )  
macrophages is in agreement with the present 
knowledge about the generation of autoimmune 
inflammations (Huitinga et al., 1992, 1995; Bauer et 
al., 1996). The macrophages (including those infil­
trated in the choroidal-subretinal space) can secrete 
m any products that may play multiple roles in non­
specific inflammatory reactions. Effector molecules 
produced by activated macrophages like eicosanoids, 
reactive oxygen species, proteinases, IL-1, IL-6, and 
TNF-& can damage the blood-ocular barriers and 
attract and activate immunocompetent cells. This is 
one of the possible explanations why early macro­
phage depletion is so effective in EAPU. The rebound 
effect two weeks afterwards may be evoked by still 
intact RPE attracting RPE-protein specific T-cells after 
th e  appearance of new macrophages. It has been 
argued that an additional important attractor of 
phagocytes in this stage may be the damage-activated 
RPE, possibly through the action of the release of 
cytokines (Broekhuyse et al., 1996). Hence, when the 
RPE has focally been destroyed (resulting in ter­
mination of cytokine release) the accumulation along 
these areas ceases, as has been noted. In view of this 
cytokine-mediated phagocyte attraction, the success­
ful suppression of EAPU by macrophage depletion after 
its onset might in addition be explained by the 
elimination of the accumulating cell type irrespective 
of its effector cell function.
Our experiments show that EMIU does not respond 
to macrophage depletion in contrast to EAPU (Table I). 
Hence, macrophages seem to be less important for the 
initiation of EMIU. Other effector cells like cytotoxic T- 
cells may exert this function (polymorphonuclear cells 
have not been found among the early invading cells). 
Thus the investigated two forms of autoantigen- 
induced uveitis in the Lewis rat could be evoked by 
more or less different immunopathogenic mechanisms 
because the injected cell-specific uveitogenic antigens 
from RPE cell membranes and choroidal melanocytes 
evoke different effector mechanisms. The immuno- 
pathogenesis of EAPU appears to be macrophage- 
dependent whereas that in EMIU is not. In both forms 
of uveitis, T-cells have been found to enter the uveal
tissue. In developing EAPU they constitute a minor
i
fraction of the invading mononuclear cells which 
consists predominantly of macrophages. However, at 
the onset of EMIU lymphoid cells virtually constitute
the entire population of the infiltrating cells in the 
uvea where the antigen is localized. The observed 
scarce presence of macrophages in the uvea at the 
onset of EMIU is in agreement with previous studies of 
Broekhuyse et al. (1991 , 1992a). Chan et al. (1994) 
reported the predominance of lymphocytes over 
macrophages during the whole course of EMIU. These 
data are in line with the above hypothesis. No primary 
RPE involvement has been noticed in EMIU that could 
result in the generation of signals like cytokine release. 
Possibly this is another reason why a massive 
macrophage influx like in EAPU is not triggered at the 
onset of EMIU. To study the significance of these 
phenomena and the role of the RPE, further immuno­
logical investigations are needed, and immunocyto- 
chemical analyses are in progress.
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